share_log

Even Though Silicon Laboratories (NASDAQ:SLAB) Has Lost US$177m Market Cap in Last 7 Days, Shareholders Are Still up 25% Over 5 Years

Even Though Silicon Laboratories (NASDAQ:SLAB) Has Lost US$177m Market Cap in Last 7 Days, Shareholders Are Still up 25% Over 5 Years

儘管硅實驗室(納斯達克股票代碼:SLAB)在過去7天內損失了1.77億美元的市值,但股東在5年內仍上漲了25%
Simply Wall St ·  05/30 06:00

While Silicon Laboratories Inc. (NASDAQ:SLAB) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 11% in the last quarter. But at least the stock is up over the last five years. In that time, it is up 25%, which isn't bad, but is below the market return of 98%.

儘管硅實驗室公司(納斯達克股票代碼:SLAB)的股東們可能普遍感到高興,但該股最近的表現並不特別好,上個季度股價下跌了11%。但至少該股在過去五年中有所上漲。在此期間,它上漲了25%,這還不錯,但低於98%的市場回報率。

Although Silicon Laboratories has shed US$177m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns.

儘管Silicon Laboratories本週的市值下跌了1.77億美元,但讓我們來看看其長期基本面趨勢,看看它們是否推動了回報。

Given that Silicon Laboratories didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. When a company doesn't make profits, we'd generally hope to see good revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

鑑於Silicon Laboratories在過去十二個月中沒有盈利,我們將專注於收入增長,以快速了解其業務發展。當一家公司沒有盈利時,我們通常希望看到良好的收入增長。那是因爲如果收入增長可以忽略不計,而且從不盈利,就很難確信一家公司能否實現可持續發展。

For the last half decade, Silicon Laboratories can boast revenue growth at a rate of 5.9% per year. That's not a very high growth rate considering the bottom line. Like its revenue, its share price gained over the period. The increase of 4% per year probably reflects the modest revenue growth. It seems likely that we'll have to zoom in on the data, including profits, to understand if there is an opportunity here.

在過去的五年中,硅實驗室可以以每年5.9%的速度實現收入增長。考慮到底線,這不是一個很高的增長率。與收入一樣,其股價在此期間上漲。每年4%的增長可能反映了收入的溫和增長。看來我們可能必須放大數據,包括利潤,才能了解這裏是否有機會。

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

您可以在下面看到收入和收入如何隨着時間的推移而變化(點擊圖片了解確切的值)。

earnings-and-revenue-growth
NasdaqGS:SLAB Earnings and Revenue Growth May 30th 2024
NASDAQGS: SLAB 收益和收入增長 2024 年 5 月 30 日

Silicon Laboratories is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. If you are thinking of buying or selling Silicon Laboratories stock, you should check out this free report showing analyst consensus estimates for future profits.

Silicon Laboratories是一隻知名股票,分析師報道豐富,這表明未來增長有一定的可見性。如果您正在考慮買入或賣出Silicon Laboratories的股票,則應查看這份免費報告,該報告顯示了分析師對未來利潤的共識估計。

A Different Perspective

不同的視角

Investors in Silicon Laboratories had a tough year, with a total loss of 13%, against a market gain of about 27%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. On the bright side, long term shareholders have made money, with a gain of 4% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. If you would like to research Silicon Laboratories in more detail then you might want to take a look at whether insiders have been buying or selling shares in the company.

硅實驗室的投資者經歷了艱難的一年,總虧損了13%,而市場漲幅約爲27%。即使是優質股票的股價有時也會下跌,但我們希望在過於感興趣之前看到企業基本指標的改善。好的一面是,長期股東賺了錢,在過去的五年中,每年增長4%。最近的拋售可能是一個機會,因此可能值得查看基本面數據以尋找長期增長趨勢的跡象。如果你想更詳細地研究硅實驗室,那麼你可能需要看看內部人士是否在買入或賣出該公司的股票。

But note: Silicon Laboratories may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

但請注意:硅實驗室可能不是最好的買入股票。因此,來看看這份過去盈利增長(以及進一步增長預測)的有趣公司的免費清單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論